Filter
2952
Filtered Results: 2952
Text search:
National
Tuberculosis
Control
Strategic
Plan
Featured
Recommendations
269
New Publications
903
Language
Document type
No document type
1849
Studies & Reports
442
Guidelines
326
Strategic & Response Plan
139
Manuals
126
Training Material
24
Situation Updates
20
Fact sheets
14
Infographics
6
Resource Platforms
4
Brochures
1
App
1
Countries / Regions
India
138
Global
117
Kenya
102
South Africa
77
Western and Central Europe
73
Ethiopia
72
Uganda
71
Tanzania
70
Nigeria
67
Nepal
61
Malawi
61
Zambia
55
Liberia
55
Ghana
52
Sierra Leone
47
Rwanda
46
Africa
45
Myanmar / Burma
44
Namibia
41
Bangladesh
39
Eastern Europe
38
Lesotho
35
Latin America and the Carribbean
34
Ukraine
32
Asia
30
Cambodia
26
Zimbabwe
23
Philippines
23
South–East Asia Region
23
Argentina
21
Colombia
20
Mozambique
20
Indonesia
20
Botswana
18
Senegal
17
Venezuela
17
Paraguay
17
Peru
14
Bolivia
14
Russia
14
East and Southern Africa
12
El Salvador
11
South Sudan
11
Brazil
10
Pakistan
10
Syria
9
Haiti
9
Congo, Democratic Republic of
9
Cameroon
8
Albania
8
Germany
8
West and Central Africa
8
Eswatini/ Swaziland
8
Burkina Faso
7
Moldova
7
Georgia
7
Tajikistan
6
Thailand
6
Benin
6
Chile
6
Guinea
6
Eastern Europe and Central Asia
6
Papua New Guinea
6
Ecuador
6
Middle East and North Africa
5
North America
5
Sudan
5
Somalia
5
Timor Leste/ East Timor
4
Afghanistan
4
Armenia
4
Jordan
4
Lebanon
4
Yemen
4
North Macedonia
3
Laos
3
Hungary
3
Western Pacific Region
3
Sri Lanka
3
Romania
3
Poland
3
Gambia
2
China
2
Iran
2
Morocco
2
Saudi Arabia
2
Uruguay
2
Turkmenistan
2
Japan
2
Southern Africa
2
Vietnam
2
Mali
2
Bhutan
2
Iraq
2
North Korea
1
Switzerland
1
Mexico
1
Serbia
1
Estonia
1
Kyrgyzstan
1
Burundi
1
Qatar
1
Bulgaria
1
Dominican Republic
1
Guinea-Bissau
1
Gabon
1
Jamaica
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Norway
1
Portugal
1
Djibouti
1
Egypt
1
Slovakia
1
Greece
1
Palestine
1
Central African Republic
1
Honduras
1
Angola
1
Chad
1
Libya
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1396
Clinical Guidelines
193
Public Health
175
Key Resources
99
Women & Child Health
86
Pharmacy & Technologies
24
Capacity Building
23
Annual Report MEDBOX
1
Toolboxes
TB
453
HIV
404
AMR
132
COVID-19
123
Mental Health
71
NCDs
55
Rapid Response
54
Health Financing Toolbox
52
Global Health Education
52
Caregiver
51
Planetary Health
51
Pharmacy
47
NTDs
47
Conflict
38
Ebola & Marburg
26
Refugee
25
Disability
24
Polio
19
Malaria
15
Natural Hazards
12
Cholera
3
Zika
3
Specific Hazards
2
South Sudan
1
Social Ethics
1
2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A
New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduct national medicine prices and availability surveys. This second edition of the survey manual has been...
The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, inpatient and outpatient services. They are also directed at policy-makers, health-care planners and programme managers, academic institutions, non-gover...
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information...
Laboratory biosafety manual
recommended
4th edition
The WHO Laboratory Biosafety Manual (LBM) has been in broad use at all levels of clinical and public health laboratories, and other biomedical sectors globally, serving as a de facto global standard that presents best practices and sets trends in biosafety.
LBM encouraged countries t...
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
There is paucity of data on the burden and specific drivers operative in the pathogenesis of chronic obstructive pulmonary disease (COPD) in the African setting and populations. Lack of awareness and inadequate knowledge on the aetio-pathogenesis of the disease together with inadequate capacity for ...
Updated with information on Ebola virus disease and Middle East respiratory syndrome coronavirus
A wide variety of health events ranging in severity may occur related to air transport, requiring different responses or, perhaps, no response at all. The target audience for this guidance document incl...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
Unstable settings present challenges for the effective provision of antiretroviral treatment (ART). In this paper, we summarize the experience and results of providing ART and implementing contingency plans during acute instability in the Central African Republic (CAR) and Yemen.
The Covid-19 pandemic has so far infected more than 30 million people in the world, having major impact on global health with collateral damage. In Mozambique, a public state of emergency was declared at the end of March 2020. This has limited people's movements and reduced public services, leading ...
The global tripartite self-assessment survey of country progress in addressing antimicrobial resistance (AMR) is a component of a broader approach for monitoring and evaluation of the global action plan on AMR. This report analyses the results of the second tripartite self-assessment survey. It has ...
Asthma is the most common chronic condition in children worldwide. It affects daytime activities, sleep and school attendance and causes anxiety to parents, families and other carers. The quality of asthma diagnosis and management globally still needs substantial improvement. From infancy to the tee...
Financing Global Health 2013: Transition in an Age of Austerity, IHME’s fifth annual report on global health expenditure, depicts financing trends that underline the resilience of development assistance for health. This year’s updated estimates show that despite lackluster economic growth and fi...
This guide is an attempt to redress the deficit in understanding of implementation research and to encourage programme personnel and implementers to take a greater interest in the subject, recognizing that implementation research is in fact an integral part of programme planning and execution, rathe...
This manual was designed to support the GRN-UNICEF Youth Health and Development Programme with the aim of sustaining My Future is My Choice graduates and other young people’s peer education activities. It was written and reviewed in a three-day workshop in November 1999 and in the following weeks ...
This report reviews the latest evidence on what works to reduce HIV-related stigma and discrimination through key programmes to reduce stigma and discrimination and increase access to justice in the six settings of focus for the Global Partnership. It includes guidance for national governments and k...
It estimates that there have been 228,000 additional deaths of children under five in these six countries [Afghanistan, Nepal, Bangladesh, India, Pakistan and Sri Lanka] due to crucial services, ranging from nutrition benefits to immunisation, being halted.
It says the number of children being tr...
This document aims to assist policy‑makers, health care providers and researchers to understand key concepts in health ethics and to identify basic ethical questions surrounding health and health care. It illustrates the challenges of applying ethical principles to global public health and outline...
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are...
The World Health Organization was requested by Member States to develop a global priority pathogens list (global PPL) of antibiotic-resistant bacteria to help in prioritizing the research and development (R&D) of new and effective antibiotic treatments. To date, the selection of pathogens for R&D ac...
